- Home
- ICCC vs BNR Comparison
ICCC vs BNR Comparison
Compare ICCC & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- BNR
- Stock Information
- Founded
- ICCC 1982
- BNR 2014
- Country
- ICCC United States
- BNR China
- Employees
- ICCC N/A
- BNR N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- BNR Medical Specialities
- Sector
- ICCC Health Care
- BNR Health Care
- Exchange
- ICCC Nasdaq
- BNR Nasdaq
- Market Cap
- ICCC 28.0M
- BNR 28.6M
- IPO Year
- ICCC 1987
- BNR 2020
- Fundamental
- Price
- ICCC $3.66
- BNR $5.38
- Analyst Decision
- ICCC
- BNR
- Analyst Count
- ICCC 0
- BNR 0
- Target Price
- ICCC N/A
- BNR N/A
- AVG Volume (30 Days)
- ICCC 14.5K
- BNR 20.0K
- Earning Date
- ICCC 11-13-2024
- BNR 11-29-2024
- Dividend Yield
- ICCC N/A
- BNR N/A
- EPS Growth
- ICCC N/A
- BNR N/A
- EPS
- ICCC N/A
- BNR N/A
- Revenue
- ICCC $23,838,002.00
- BNR $70,154,674.00
- Revenue This Year
- ICCC N/A
- BNR $52.90
- Revenue Next Year
- ICCC N/A
- BNR $48.35
- P/E Ratio
- ICCC N/A
- BNR N/A
- Revenue Growth
- ICCC 46.37
- BNR N/A
- 52 Week Low
- ICCC $3.34
- BNR $2.62
- 52 Week High
- ICCC $5.59
- BNR $9.99
- Technical
- Relative Strength Index (RSI)
- ICCC 54.28
- BNR 80.41
- Support Level
- ICCC $3.40
- BNR $4.55
- Resistance Level
- ICCC $3.64
- BNR $3.89
- Average True Range (ATR)
- ICCC 0.16
- BNR 0.42
- MACD
- ICCC 0.01
- BNR 0.23
- Stochastic Oscillator
- ICCC 65.12
- BNR 99.26
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.